Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sofia Aakko"'
Autor:
Mika Kontro, Timo Siitonen, Johanna Rimpilainen, Marja Pyorala, Inka Pawlitzky, Sofia Aakko, Marie-Louise Fjaellskog, Maija Hollmén, Naval Daver
Publikováno v:
HemaSphere, Vol 7, p e682099c (2023)
Externí odkaz:
https://doaj.org/article/cb629aa0ace24d6c91daaa964f27d07a
Autor:
Arafat Siddiqui, Manuela Tumiati, Alia Joko, Jouko Sandholm, Pia Roering, Sofia Aakko, Reetta Vainionpää, Katja Kaipio, Kaisa Huhtinen, Liisa Kauppi, Johanna Tuomela, Sakari Hietanen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Critical DNA repair pathways become deranged during cancer development. This vulnerability may be exploited with DNA-targeting chemotherapy. Topoisomerase II inhibitors induce double-strand breaks which, if not repaired, are detrimental to the cell.
Externí odkaz:
https://doaj.org/article/6a72803515b2449c90dd67582d36c593
Autor:
Sofia Aakko, Anne Hege Straume, Einar Elvbakken Birkeland, Ping Chen, Xi Qiao, Per Eystein' 'Lønning, Marko J. Kallio
Publikováno v:
Translational Oncology, Vol 12, Iss 1, Pp 170-179 (2019)
Taxanes are chemotherapeutic agents used in the treatment of solid tumors, particularly of breast, ovarian, and lung origin. However, patients show divergent therapy responses, and the molecular determinants of taxane sensitivity have remained elusiv
Externí odkaz:
https://doaj.org/article/882708b2dee8437db0dcdf260e5b1495
Autor:
Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela, Aino-Maija Leppä, Jani Huuhtanen, Ida Vänttinen, Petra Nygren, Jay Klievink, Jonas Bouhlal, Petri Pölönen, Qi Zhang, Shady Adnan-Awad, Cristina Mancebo-Pérez, Joseph Saad, Juho Miettinen, Komal K. Javarappa, Sofia Aakko, Tanja Ruokoranta, Samuli Eldfors, Merja Heinäniemi, Kim Theilgaard-Mönch, Ulla Wartiovaara-Kautto, Mikko Keränen, Kimmo Porkka, Marina Konopleva, Krister Wennerberg, Mika Kontro, Caroline A. Heckman, Satu Mustjoki
Funding Information: This study was supported by the Cancer Foundation Finland, the Helsinki Institute of Life Science (HiLIFE) Fellow grants, the Academy of Finland (grant 1320185 ), the Sigrid Jusélius Foundation , the Finnish Cancer Institute , t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148477e5b4c49fcc3edbc9051a7877b4
https://aaltodoc.aalto.fi/handle/123456789/120373
https://aaltodoc.aalto.fi/handle/123456789/120373
Autor:
Olli Dufva, Heikki Kuusanmäki, Markus Vaha-Koskela, Aino-Maija Leppä, Jani Huuhtanen, Ida Vänttinen, Petra Johanna Nygren, Jay Klievink, Jonas Bouhlal, Petri Pölönen, Qi Zhang, Shady Adnan Awad, Cristina Mancebo, Joseph Saad, Juho J. Miettinen, Komal Kumar Javarappa, Sofia Aakko, Tanja Ruokoranta, Samuli Eldfors, Merja Heinäniemi, Ulla Wartiovaara-Kautto, Marina Konopleva, Mikko A Keränen, Kimmo Porkka, Krister Wennerberg, Mika Kontro, Caroline A. Heckman, Satu Mustjoki
Publikováno v:
Blood. 140:101-103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbf07913c7d5bc1709c3fe4e4dbd0f1c
https://doi.org/10.1182/blood-2022-158694
https://doi.org/10.1182/blood-2022-158694
Autor:
Arno Ylitalo, Sofia Aakko, Heikki Kuusanmäki, Mari Björkman, Juho Jalkanen, Marie-Louise Fjällskog, Caroline Heckman, Maija Hollmén, Mika Kontro
Publikováno v:
Blood Cancer Discovery. 4:A14-A14
The potential of immunotherapies in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) remains still under investigation. Clever-1 (also known as Stabilin-1) is a multifunctional scavenger and adhesion receptor expressed by monocytes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7372f125d6927a2037dd329fcbef3c3
https://doi.org/10.1158/2643-3249.aml23-a14
https://doi.org/10.1158/2643-3249.aml23-a14
Autor:
Ping Chen, Marko J. Kallio, Anne Hege Straume, Einar Elvbakken Birkeland, Sofia Aakko, Xi Qiao, Per Eystein Lønning
Publikováno v:
Translational Oncology
Translational Oncology, Vol 12, Iss 1, Pp 170-179 (2019)
Translational Oncology, Vol 12, Iss 1, Pp 170-179 (2019)
Taxanes are chemotherapeutic agents used in the treatment of solid tumors, particularly of breast, ovarian, and lung origin. However, patients show divergent therapy responses, and the molecular determinants of taxane sensitivity have remained elusiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5342c2ac9bf2d384c5c8d46f2f13b5
https://hdl.handle.net/1956/22675
https://hdl.handle.net/1956/22675